McKesson Corporation

MCK Healthcare Medical Distribution

McKesson Corporation’s revenue for fiscal 2026 (year ended March 2026) was $403.4 billion, up 12.4% from fiscal 2025.

Revenue
+7.57%
EPS
+17.0%
Free cash flow
+32.5%
Total debt
+7.08%

Quarter to September 2026, against a year earlier

1,065.87 6.13 −0.57%
Market cap
$125.0B
P/E
27.5×
Fwd P/E
25.4×
Dividend yield
0.32%
F-score
7/9
Altman Z
6.15
Beneish M
−2.34
Dividend safety
86/100
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 Mar '20 Mar '19 Mar '18 Mar '17
Piotroski F-Score
7 6 5 7 7 4 7 7 6 4
P/E ratio
22.40 25.92 23.81 14.13 41.94 0.00 26.06 1,485.50 607.87 6.29
Altman Z-Score
6.15 5.88 5.63 5.35 4.86 3.90 4.46 4.22 4.15 4.37
P/S ratio
0.27 0.24 0.23 0.18 0.18 0.13 0.11 0.11 0.14 0.17
Altman Z″-Score (non-manufacturers)
0.59 0.61 0.66 0.71 0.42 0.02 1.02 1.04 1.04 1.87
P/FCF ratio
19.77 16.41 19.70 10.92 11.96 8.03 6.32 6.71 7.72 7.83
P/Operating CF
31.27 11.07 17.23 15.11 16.15 9.29 5.25 5.99 9.62 22.83
Beneish M-Score
(2.34) (2.42) (2.42) (2.38) (2.78) (3.19) (2.60) (2.81) (2.86) (2.29)
Dividend Safety Score
86 — — — — — — — — —
P/B ratio
0.00 0.00 0.00 0.00 0.00 178.99 4.60 2.82 2.89 2.91
EV/Sales
0.28 0.25 0.25 0.21 0.21 0.17 0.12 0.13 0.16 0.19
EV/EBITDA
16.51 18.05 17.30 11.58 20.08 0.00 7.83 7.14 8.72 4.63
EV/FCF
21.18 17.47 21.68 12.56 14.41 10.32 7.19 8.03 9.11 9.21
Current Ratio
0.85 0.90 0.92 0.92 0.95 1.03 0.99 1.02 1.01 1.04
Net Debt/EBITDA
1.10 1.10 1.58 1.51 3.42 (2.29) 0.95 1.18 1.33 0.69
Debt/Equity
(6.54) (6.64) (7.34) (8.20) (7.31) 86.94 1.39 0.92 0.78 0.76
ROE
(274.39%) (200.12%) (194.37%) (216.94%) (137.79%) (165.54%) 13.24% 0.37% 0.63% 50.00%
ROA
6.05% 4.62% 4.63% 5.67% 1.74% (7.19%) 1.49% 0.06% 0.11% 8.63%
ROIC
66.20% 71.41% 43.94% 45.25% 16.38% (34.57%) 17.92% 4.29% 3.12% 26.13%
Return on Tangible Assets
(66.70%) (88.96%) (144.95%) (239.25%) (779.02%) (117.59%) 45.85% 1.00% 2.30% 139.75%
Average Days of Receivables
25.32 26.07 25.54 25.60 25.70 29.39 31.52 31.07 31.03 33.49
Earnings Yield
4.47% 3.86% 4.20% 7.07% 2.38% (14.63%) 3.84% 0.07% 0.16% 15.89%
Free Cash Flow Yield
5.06% 6.10% 5.08% 9.16% 8.36% 12.45% 15.83% 14.91% 12.95% 12.76%
Free Cash Flow per Share
43.77 41.02 27.23 32.61 25.60 24.29 21.42 17.72 18.10 18.92
Book value per Share
(14.38) (13.30) (12.00) (10.56) (11.77) 1.09 29.40 42.22 48.35 51.01
Free Cash Flow
5,410.00 5,226.00 3,627.00 4,601.00 3,899.00 3,901.00 3,868.00 3,479.00 3,765.00 4,182.00
EV/EBIT
18.45 20.65 20.11 13.19 27.57 0.00 11.17 31.54 45.00 5.41
Other line items

Show all line items

Columns are period end dates · fundamentals updated 4 Nov 2026